0001214659-21-013288.txt : 20211216 0001214659-21-013288.hdr.sgml : 20211216 20211216170017 ACCESSION NUMBER: 0001214659-21-013288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211214 FILED AS OF DATE: 20211216 DATE AS OF CHANGE: 20211216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUSTAFSON MARK CENTRAL INDEX KEY: 0001303996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 211498394 MAIL ADDRESS: STREET 1: 10691 ROSECROFT CRESCENT CITY: RICHMOND STATE: A1 ZIP: V7A 2H9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 4 1 marketforms-54671.xml PRIMARY DOCUMENT X0306 4 2021-12-14 0001677077 Alzamend Neuro, Inc. ALZN 0001303996 GUSTAFSON MARK 3802 SPECTRUM BOULEVARD, SUITE 112C TAMPA FL 33612 true false false false Common Stock 2021-12-14 4 S false 20000 2.8543 D 30000 D The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8543. The range of sale prices on the transaction date was $2.85 to $2.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price /s/ Mark Gustafson 2021-12-16